EICHOR
● Active Not Recruiting
Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension
Condition: Hypertension · Hypertension,Essential · Sponsor: ADARx Pharmaceuticals, Inc.
About this study
This Phase 1 study will evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of ADX-850 in participants with hypertension.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (3)
| CMAX Clinical Research | Adelaide, South Australia, Australia | — |
| Linear Clinical Research | Nedlands, Western Australia, Australia | — |
| Clinitrials Pty Ltd | Perth, Australia | — |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.